PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.20 and traded as high as $0.21. PURE Bioscience shares last traded at $0.21, with a volume of 14,550 shares traded.

PURE Bioscience Trading Up 4.9 %

The firm has a market capitalization of $18.48 million, a price-to-earnings ratio of -5.25 and a beta of 0.01. The stock's 50 day moving average price is $0.21 and its two-hundred day moving average price is $0.20.

About PURE Bioscience

(Get Rating)

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.

Featured Stories

• Get a free copy of the StockNews.com research report on PURE Bioscience (PURE)
• This Little Known Small Cap Is Up 139%: Is The Stock A Buy?
• A Trio of Q3 Winners With Room to Run
• Can HCA Healthcare Weather the Normalization?
• Can United Natural Foods Fight Both Inflation and the Fed?
• Mullen Automotive Is Ready To Get In Gear

Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.